BYDs Latest 4nm SelfDriving Chip Fails to Alleviate Growth Concerns Among Investors Tempest Therapeutics Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage US Payrolls Surpass Expectations in April Yet Underlying Red Flags Emerge